Advanced Malignancy
Pipeline by Development Stage
Drug Modality Breakdown
Competitive Landscape
9 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (10)
Total enrollment: 928 patients across 10 trials
A Study of Anlotinib in Subjects With Advanced Malignancy
ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers
Study of IBI318 in Participants With Advanced Malignancies
A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors
Safety Study of AMG 228 to Treat Solid Tumors
A Phase 1b/2a Study Evaluating AMG 232 in Metastatic Melanoma
A Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid Leukemia
A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
A Study of AMG 337 in Subjects With Advanced Solid Tumors
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.